InvestorsHub Logo
Followers 4054
Posts 151324
Boards Moderated 4
Alias Born 08/05/2009

Re: Woody Driver post# 236

Friday, 06/22/2018 7:02:18 AM

Friday, June 22, 2018 7:02:18 AM

Post# of 282
Oppenheimer analyst Steven Lichtman maintained a Buy rating on Tandem Diabetes (NASDAQ: TNDM) today and set a price target of $24. The company’s shares closed yesterday at $20.31, close to its 52-week high of $21.50.


http://www.analystratings.com/articles/oppenheimer-sticks-to-its-buy-rating-for-tandem-diabetes/

Always consult an Investment Professional, my posts are my own
opinions, and not for investing decisions!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNDM News